Skip to main content

John Weis Comment On Regulatory Notice 22-08

John Weis
N/A

I am writing concerning the proposed restricting investors access to complex products such as ProShares inverse funds. I have been using such funds as a hedge on my common stocks, so far with great success. The decline in my stocks has been more than offset by gains on my inverse bond ETFs. As a small investor my only access to derivatives is through such funds and restricting access would greatly limit my ability to hedge my investments. As a result, I oppose any such move by FINRA.